These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2161300)

  • 1. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism.
    Logue FC; Fraser WD; Gallacher SJ; Cameron DA; O'Reilly DS; Beastall GH; Patel U; Boyle IT
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):475-83. PubMed ID: 2161300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the circadian rhythm of intact parathyroid hormone following a 96-hour fast.
    Fraser WD; Logue FC; Christie JP; Cameron DA; O'Reilly DS; Beastall GH
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):523-8. PubMed ID: 8187320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circadian rhythm of intact parathyroid hormone (1-84) and nephrogenous cyclic adenosine monophosphate in normal men.
    Logue FC; Fraser WD; O'Reilly DS; Beastall GH
    J Endocrinol; 1989 Apr; 121(1):R1-3. PubMed ID: 2541215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC; Bower RH; Sode J
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythm and pulsatility of parathyroid hormone secretion in man.
    Herfarth K; Schmidt-Gayk H; Graf S; Maier A
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):511-9. PubMed ID: 1286521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythms for calcium, inorganic phosphorus, and parathyroid hormone in primary hyperparathyroidism: functional and practical considerations.
    Lobaugh B; Neelon FA; Oyama H; Buckley N; Smith S; Christy M; Leight GS
    Surgery; 1989 Dec; 106(6):1009-16; discussion 1016-7. PubMed ID: 2588106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.
    Ahmad AM; Hopkins MT; Fraser WD; Ooi CG; Durham BH; Vora JP
    Bone; 2003 Feb; 32(2):170-9. PubMed ID: 12633789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels.
    Jubiz W; Canterbury JM; Reiss E; Tyler FH
    J Clin Invest; 1972 Aug; 51(8):2040-6. PubMed ID: 5054463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary hyperparathyroidism: value of "intact parathormone" assay (PTH 1-84)].
    Guillemant S; Guillemant J; Oberlin F; Dairou F; Camus JP
    Presse Med; 1989 Oct; 18(31):1509-12. PubMed ID: 2554272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary cyclic AMP:creatinine ratio and nephrogenous cyclic AMP as indicators parathyroid functional status.
    Stuart CA; Prochnow PA
    Endocr Res; 1986; 12(1):49-67. PubMed ID: 3009173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
    Bill G; Jacquet AF; Burckhardt P
    Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
    Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease.
    Fraser WD; Logue FC; MacRitchie K; Wilson RM; Gray HW; Beastall GH; O'Reilly DS
    Acta Endocrinol (Copenh); 1991 Jun; 124(6):652-7. PubMed ID: 1648852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
    Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of renal cyclic adenosine monophosphate, serum parathyroid hormone and phosphate reabsorption in recurrent calcium urolithiasis, healthy controls and hyperparathyroidism (author's transl)].
    Schwille PO; Bornhof C; Thun R; Scholz D; Bötticher R; Schellerer W; Sigel A
    Klin Wochenschr; 1978 Jun; 56(12):601-6. PubMed ID: 210311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.